Human immunodeficiency virus and liver disease forum 2010: Conference proceedings
Kenneth E. Sherman, David L. Thomas, Raymond T. Chung – 2 December 2011 – Liver disease continues to represent a critical mediator of morbidity and mortality in those with human immunodeficiency virus (HIV) infection. The frequent presence and overlap of concomitant injurious processes, including hepatitis C virus and hepatitis B virus infections, hepatoxicity associated with antiretroviral therapeutic agents, alcohol, and other toxins, in the setting of immunosuppression lead to rapid fibrotic progression and early development of end‐stage liver disease.